Assessing osteoporosis and bone mineral density through

18F-Sodium fluoride Bone mineral density Osteoporosis PET/CT Quantitative analysis

Journal

Annals of nuclear medicine
ISSN: 1864-6433
Titre abrégé: Ann Nucl Med
Pays: Japan
ID NLM: 8913398

Informations de publication

Date de publication:
24 Sep 2024
Historique:
received: 11 04 2024
accepted: 17 09 2024
medline: 25 9 2024
pubmed: 25 9 2024
entrez: 24 9 2024
Statut: aheadofprint

Résumé

The use of In this retrospective study, 199 patients (average age 56 ± 6, comprising 52 males and 147 females) with a history of cancer were analyzed. Each participant underwent both A total of 796 lumbar vertebrae from 199 patients were measured. It was observed that osteoporotic patients had significantly lower This study demonstrates distinct

Identifiants

pubmed: 39317874
doi: 10.1007/s12149-024-01982-w
pii: 10.1007/s12149-024-01982-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Health Commission of Guangxi Zhuang Autonomous Region
ID : Z-C20220815

Informations de copyright

© 2024. The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine.

Références

Jadvar H, Desai B, Conti PS. Sodium 18F-fluoride PET/CT of bone, joint, and other disorders. Semin Nucl Med. 2015;45:58–65.
doi: 10.1053/j.semnuclmed.2014.07.008 pubmed: 25475379 pmcid: 4258001
Blake GM, ParkHolohan SJ, Cook GJ, Fogelman I. Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate. Semin Nucl Med. 2001;31:28–49.
doi: 10.1053/snuc.2001.18742 pubmed: 11200203
Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST. Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med. 2008;49:68–78.
doi: 10.2967/jnumed.106.037200 pubmed: 18077529
Park PSU, Resto DA, Khurana N, Raynor WY, Werner TJ, Høilund-Carlsen PF, et al. The utility of 18F-NaF-Positron Emission tomography/computed tomograp hy in measuring the metabolic activity of the aging spine : implicatio ns for osteoporosis. Spine (Phila Pa 1976). 2023;48:1064–1071.
Sheppard AJ, Paravastu SS, Wojnowski NM, Osamor CC 3rd, Farhadi F, Collins MT, et al. Emerging Role of 18F-NaF PET/computed tomographic imaging in osteoporosis: a potential upgrade to the osteoporosis toolbox. PET Clin. 2023;18:1–20.
doi: 10.1016/j.cpet.2022.09.001 pubmed: 36442958 pmcid: 9773817
Prevention and management of osteoporosis. World Health Organ Tech Rep Ser. 2003;921.
Morgan EF, Unnikrisnan GU, Hussein AI. Bone mechanical properties in healthy and diseased states. Annu Rev Biomed Eng. 2018;20:119–43.
doi: 10.1146/annurev-bioeng-062117-121139 pubmed: 29865872 pmcid: 6053074
Clynes MA, Harvey NC, Curtis EM, Fuggle NR, Dennison EM, Cooper C. The epidemiology of osteoporosis. Br Med Bull. 2020;133:105–17.
pubmed: 32282039
Gruenewald LD, Koch V, Martin SS, Yel I, Eichler K, Gruber-Rouh T, et al. Diagnostic accuracy of quantitative dual-energy CT-based volumetric bone mineral density assessment for the prediction of osteoporosis-associated fractures. Eur Radiol. 2022;32:3076–84.
doi: 10.1007/s00330-021-08323-9 pubmed: 34713330
Wichmann JL, Booz C, Wesarg S, Kafchitsas K, Bauer RW, Kerl JM, et al. Dual-energy CT-based phantomless in vivo three-dimensional bone mineral density assessment of the lumbar spine. Radiology. 2014;271:778–84.
doi: 10.1148/radiol.13131952 pubmed: 24475863
Brett AD, Brown JK. Quantitative computed tomography and opportunistic bone density screening by dual use of computed tomography scans. J Orthop Translat. 2015;3:178–84.
doi: 10.1016/j.jot.2015.08.006 pubmed: 30035056 pmcid: 5986997
Michalski AS, Besler BA, Burt LA, Boyd SK. Opportunistic CT screening predicts individuals at risk of major osteoporotic fracture. Osteoporos Int. 2021;32:1639–49.
doi: 10.1007/s00198-021-05863-0 pubmed: 33566138
Huang K, Feng Y, Liu D, Liang W, Li L. Quantification evaluation of 99mTc-MDP concentration in the lumbar spine with SPECT/CT: compare with bone mineral density. Ann Nucl Med. 2020;34:136–43.
doi: 10.1007/s12149-019-01425-x pubmed: 31768820
Beheshti M, Mottaghy FM, Paycha F, Behrendt FFF, Van den Wyngaert T, Fogelman I, et al.
doi: 10.1007/s00259-015-3138-y pubmed: 26201825
Kanis JA. Assessment of osteoporosis at the primary health care level. 2007.
Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137–41.
doi: 10.1002/jbmr.5650090802 pubmed: 7976495
Wong KK, Piert M. Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: me chanisms and applications. J Nucl Med. 2013;54:590–9.
doi: 10.2967/jnumed.112.114298 pubmed: 23482667
Bastawrous S, Bhargava P, Behnia F, Djang DSW, Haseley DR. Newer PET application with an old tracer: role of
doi: 10.1148/rg.345130061 pubmed: 25208282
Frost ML, Moore AE, Siddique M, Blake GM, Laurent D, Borah B, et al. 1⁸F-fluoride PET as a noninvasive imaging biomarker for determining treatment efficacy of bone active agents at the hip: a prospective, randomized, controlled clinical study. J Bone Miner Res. 2013;28:1337–47.
doi: 10.1002/jbmr.1862 pubmed: 23322666
Assiri R, Knapp K, Fulford J, Chen J. Correlation of the quantitative methods for the measurement of bone uptake and plasma clearance of 18F-NaF using positron emission tomography. Systematic review and meta-analysis. Eur J Radiol. 2022;146:110081.
doi: 10.1016/j.ejrad.2021.110081 pubmed: 34911006
Ahuja K, Sotoudeh H, Galgano SJ, Singh R, Gupta N, Gaddamanugu S, et al.
doi: 10.2967/jnmt.119.234336 pubmed: 31811067
Jassel IS, Siddique M, Frost ML, Moore AEB, Puri T, Blake GM. The influence of CT and dual-energy X-ray absorptiometry (DXA) bone de nsity on quantitative [18F]sodium fluoride PET. Quant Imaging Med Surg. 2019;9:201–9.
doi: 10.21037/qims.2019.01.01 pubmed: 30976544 pmcid: 6414779

Auteurs

Jinquan Huang (J)

Department of Nuclear Medicine, Affiliated Hospital of Guilin Medical University, No. 15 Lequn Road, 541001, Xiufeng District, Guilin, 541001, Guangxi Zhuang Autonomous Region, China.

Jingze Li (J)

Department of Nuclear Medicine, Affiliated Hospital of Guilin Medical University, No. 15 Lequn Road, 541001, Xiufeng District, Guilin, 541001, Guangxi Zhuang Autonomous Region, China.

Zuguo Li (Z)

Department of Nuclear Medicine, Affiliated Hospital of Guilin Medical University, No. 15 Lequn Road, 541001, Xiufeng District, Guilin, 541001, Guangxi Zhuang Autonomous Region, China.

Jie Qin (J)

Department of Nuclear Medicine, Affiliated Hospital of Guilin Medical University, No. 15 Lequn Road, 541001, Xiufeng District, Guilin, 541001, Guangxi Zhuang Autonomous Region, China.

Xingyu Mu (X)

Department of Nuclear Medicine, Affiliated Hospital of Guilin Medical University, No. 15 Lequn Road, 541001, Xiufeng District, Guilin, 541001, Guangxi Zhuang Autonomous Region, China. muxingyu1992@hotmail.com.

Wei Fu (W)

Department of Nuclear Medicine, Affiliated Hospital of Guilin Medical University, No. 15 Lequn Road, 541001, Xiufeng District, Guilin, 541001, Guangxi Zhuang Autonomous Region, China. fuwei19700513@163.com.

Classifications MeSH